Who Won It

Contract award · 27 Mar 2026

NP90726l Tildrakizumab (Ilumetri®)

The Common Services Agency (more commonly known as Public Service Delivery Scotland) (PSDS) awarded “NP90726l Tildrakizumab (Ilumetri®)” to Almirall Ltd for £2.69m on 27 Mar 2026. Awarded without open competition.

No competitionMedical equipment & pharmaceuticalsScotland

BuyerThe Common Services Agency (more commonly known as Public Service Delivery Scotland) (PSDS)
Value £2.69m
WinnerAlmirall Ltd

Awarded without open competition

Awarded without open competition. The buyer went directly to one or a few suppliers instead of advertising the contract. Procurement rules allow this only in specific cases, such as extreme urgency, when only one supplier can do the work, or for call-offs from an existing framework.

What “without competition” means

Buyer
The Common Services Agency (more commonly known as Public Service Delivery Scotland) (PSDS) · Body governed by public law
Supplier
Almirall Ltd
Value
£2,686,251
Procedure
Award procedure without prior publication of a call for competition
Sector
Medical equipment & pharmaceuticals · Pharmaceutical products (CPV 33600000)
Region
Scotland
Official notice
084864-2026 on Find a Tender
Timeline
  1. Contract date27 Mar 2026
  2. Published8 Sep 2026Published 165 days after the contract date

Description

Supply of Tildrakizumab (Ilumetri®) to NHS Scotland. The Authority has awarded this framework as a single supplier Framework per line to one (1) Framework Participant.

About the supplier

More from The Common Services Agency (more commonly known as Public Service Delivery Scotland) (PSDS)

All contracts

No contracts to show yet.

Recent medical equipment & pharmaceuticals contracts

Sector overview